Teva Pharmaceutical Industries reported its second-quarter 2025 financial results on Wednesday, reflecting a mixed performance amid continued shifts in its portfolio strategy. CEO Richard Francis speaks with Bloomberg's Scarlet Fu and Katie Griefeld.

Stew Leonard’s Wines & Spirits President Blake Leonard Talks Beverage Industry, Company Succession
08:03

Bob Hormats Talks Trump/Xi Summit
08:52

US Trade Representative Jamieson Greer Talks China Trade
13:52